Experimental study of processing of PCL (polycaprolactone)-peptides nanoparticles and its biodistribution analysis for drug delivery system

Abstract

Abstract Two types of cells targeting Peptides, TAMS-1 (CSPGAKVRCY {Lys (Biotin)}) and MDSC-peptide (Biotin {PEG4}-MEWSLEKGYTIK), were synthesized for targeting CD206 M2 macrophage and myeloid-derived suppressor cells (MDSC), respectively. Each peptide was coaxially electro sprayed where PCL (Polycaprolactone) is the core, and the peptide is the sheath to create a PCL nanoparticle with peptides. Electro spraying parameters included applying a voltage of 44 kV, humidity between 35–44%, tip to collector distance at 160 mm, core flow rate of 0.5 ml/hr, and a sheath flow rate of 0.7 ml/hr. UV–VIS (Ultraviolet–Visible) spectrometry, SEM (Scanning Electron Microscopy) imaging, and in vivo biodistribution techniques were used to study the morphology and performance of the PCL-peptide nanoparticles. Peak absorbance values for PCL were found at around 275 nm. Peptides absorbance value was observed between 230 and 250 nm. Scanning Electron Microscope image shows nanoparticles as small as 100 nm and agglomerates as large as 1 µm. In-vivo biodistribution of PCL and CD206 M2 macrophage targeting peptide (TAMS-1) nanoparticles after intravenous injection in the tumor mice model showed uptake to the tumors. On the other hand, MDSC peptide did not show any uptake to the site of tumors. Most activity is shown in the intestine indicating excretion of the agents through the hepato-biliary system.